IP Library Granted Patent US 8,278,071
Granted Patent B2
US 8,278,071 · App. 11/837,656 · Granted Oct 2, 2012

Method for detecting the presence of a single target nucleic acid in a sample

Assignees: Applied Biosystems, LLC; The United States Department of Health and Human Service
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,278,071
App. No.
11/837,656
Granted
Oct 2, 2012
Kind
B2
Abstract

A method comprising subjecting one or more sample portion(s) to a single amplification step, thereby amplifying a single molecule in the sample portion to a detectable level, and, in some embodiments, then determining whether the sample portion contains at least one molecule of the target nucleic acid. In some embodiments, the sample portion is in a porous sample structure, or in a sample chamber which comprises means for minimizing diffusion of the sample portion, or in a sample chamber which is inside a microcapillary device, or in a sample retaining means.

Claims (10)

1. A method for amplifying a target nucleic acid present in a sample, the method comprising:

combining a sample with reagents sufficient to perform a primer-based amplification reaction of at least one target nucleic acid when present;

introducing the combined sample and reagents along a passage of a microfluidic device;

introducing to the passage a fluid immiscible with the combined sample and reagents, wherein introducing the immiscible fluid segregates and entraps the combined sample and reagents into a plurality of reaction volumes ranging from 1 picoliter to 1 microliter, wherein said immiscible fluid is non-gaseous; and

collectively subjecting the plurality of reaction volumes to amplification conditions thereby amplifying the at least one target nucleic acid when present.

2. The method of claim 1 , wherein the plurality of reaction volumes range from 1 picoliter to 100 nanoliters.

3. The method of claim 1 , wherein the plurality of reaction volumes range from 1 picoliter to 10 nanoliters.

4. The method of claim 1 , wherein the immiscible fluid is oil.

5. The method of claim 1 , further comprising determining a quantity of the reaction volumes that yield amplified target nucleic acid from the collectively subjecting to the amplification conditions.

6. The method of claim 1 , wherein the reagents comprise a detectable moiety sufficient to permit detection of the amplified target nucleic acid.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY NOS.; CONVEYING PARTY INTEREST; CONVEYING PARTY NAME/ADDRESS PER MERGER RECORDED 6/9/2010, REEL 024508, FRAME 0142. PREVIOUSLY RECORDED ON REEL 023950 FRAME 0123. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 22, 2010
From: GENOMIC NANOSYSTEMS CORPORATION
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 024563/0930 →
MERGER Recorded Jun 9, 2010
From: GENOMIC NANOSYSTEMS, LLC
To: GENOMIC NANOSYSTEMS CORPORATION
Reel/Frame 024508/0142 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2010
From: GENOMIC NANOSYSTEMS, LLC
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023950/0123 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2009
From: CYTONIX CORPORATION
To: GENOMIC NANOSYSTEMS, LLC
Reel/Frame 022427/0504 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2009
From: BROWN, JAMES F.
To: CYTONIX CORPORATION
Reel/Frame 022421/0098 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2009
From: SILVER, JONATHAN E.
To: THE UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 022421/0115 →
Continuity (9)
Continuation 10798857 · Mar 11, 2004
Division 10131854 · Apr 25, 2002
Division 09563714 · May 2, 2000
Division 08838262 · Apr 17, 1997
Division 11837656
Continuation 10131854 · Apr 25, 2002
Division 09563714 · May 2, 2000
Division 08838262 · Apr 17, 1997
Related Publication 20080171327A1 · Jul 17, 2008